BioCryst
Medical AFFAIRS
Navigate the Biocryst Medical Affairs Hub with ease
Throughout this resource hub you will find up-to-date information on developing and approved BioCryst medicines, including clinical trials, congress information, published data, and other research material.
Search for medical information
Find information on BioCryst products.
Find information
on upcoming and previous congresses
Upcoming Congress Events
2025 American Academy of Otolaryngic Allergy Congress
BioCryst will attend the 2025 American Academy of Otolaryngic Allergy Congress from Nov 14-16, 2025.
Visit the Congress Website for More Information
Materials From Recent Congresses
Showing 110 Materials
-
Oral Berotralstat Reduces Hereditary Angioedema Attack Rates in Pediatric Patients Aged 2 to <12 Years Without Long-Term Prophylaxis During the 12-Week Standard of Care Period: Interim Data from the APeX-P Study
WSAAI | 2026 | HAE -
Emergency Department Experiences of Young Patients With Hereditary Angioedema and Their Caregivers (R117)
ACAAI | 2025 | HAE -
Burden of Attack for Young Patients With Hereditary Angioedema and Their Caregivers (R109)
ACAAI | 2025 | HAE -
Psychosocial Impact of Hereditary Angioedema on Young Patients and Their Caregivers (R102)
ACAAI | 2025 | HAE -
Hereditary Angioedema Attack Rates in Children 2–12 with Oral Prophylactic Berotralstat Over One Year
ACAAI | 2025 | HAE
Current clinical trials and research
Learn more about medicines being developed at BioCryst and see the latest studies.
Discover more about our areas of focus
See our video library
Learn more about research within our areas of focus.
Ready to connect or have a question?
Have questions about any of our medicines that are approved or in development, or would you like to be connected with an MSL?
Have questions about our company?